Supply shortage of Fasturtec (rasburicase) 7.5 mg/5 ml powder and solvent for concentrate for solution for infusion (EU/1/00/170/002).

Summary:

• In Italy, Fasturtec (rasburicase) 1,5 mg/ml polvere e solvente per concentrato per soluzione per infusione - 1 flaconcino 7,5 mg+ 1 fiala 5 ml uso endovenoso (AIC 035473026) is in shortage (contingency distribution plan) since 28/11/2022 and starting from 31/03/2023 it will be totally in shortage until 01/07/2024.
• If Fasturtec (rasburicase) 1,5 mg/ml polvere e solvente per concentrato per soluzione per infusione - 1 flaconcino 7,5 mg+ 1 fiala 5 ml uso endovenoso (AIC 035473026) is not available, Fasturtec (rasburicase) 1,5 mg polvere e solvente per concentrato per soluzione per infusione endovenosa -3 flaconcini + 3 fiale uso endovenoso (AIC 035473014) presentation can be used instead (the chemical and biological contents of the 7.5 mg and 1.5 mg vials are identical). In this case, the use of several vials may be necessary to obtain the quantity of rasburicase required for one administration (for the required reconstitution steps, please refer to the DHPC).